These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 14345293)

  • 21. Rectal mucosa damage in rabbits after subchronical application of suppository bases.
    De Muynck C; Cuvelier C; Van Steenkiste D; Bonnarens L; Remon JP
    Pharm Res; 1991 Jul; 8(7):945-50. PubMed ID: 1924149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Formulation and analysis of suppositories containing papaverine hydrochloride. Part 1. Choice of the optimal vehicle and determination of the physical parameters of the suppositories].
    Regdon G; Vastag T; Regdon G; Selmeczi B
    Acta Pharm Hung; 1991 Nov; 61(6):295-302. PubMed ID: 1785358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A new vehicle for suppositories].
    WIENHUSEN R
    Pharmazie; 1952 Mar; 7(3):149-50. PubMed ID: 14948487
    [No Abstract]   [Full Text] [Related]  

  • 24. Vaginal suppositories containing Lactobacillus acidophilus: development and characterization.
    Rodrigues F; Maia MJ; das Neves J; Sarmento B; Amaral MH; Oliveira MB
    Drug Dev Ind Pharm; 2015; 41(9):1518-25. PubMed ID: 25265366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Softening and liquefaction temperature of suppositories.
    SETNIKAR I; FANTELLI S
    J Pharm Sci; 1963 Jan; 52():38-43. PubMed ID: 13988205
    [No Abstract]   [Full Text] [Related]  

  • 26. [Note on the results of the use of new vehicles with base of polyethylene glycols].
    LAPIERE S; OLIVIER J
    Arch Belg Dermatol Syphiligr; 1952 Apr; 8(1):194-200. PubMed ID: 13017634
    [No Abstract]   [Full Text] [Related]  

  • 27. A study of the polyethylene glycols as vehicles for intramuscular and subcutaneous Injection.
    CARPENTER CP; SHAFFER CB
    J Am Pharm Assoc Am Pharm Assoc; 1952 Jan; 41(1):27-9. PubMed ID: 14907489
    [No Abstract]   [Full Text] [Related]  

  • 28. Continuous flow bead-bed dissolution apparatus for suppositories.
    Roseman TJ; Derr GR; Nelson KG; Lieberman BL; Butler SS
    J Pharm Sci; 1981 Jun; 70(6):646-51. PubMed ID: 7252809
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Studies of the rectal resorption of strychnine sulfate from suppositories prepared with indigenous excipients].
    Verbuţă A; Pavelescu M; Moisă L
    Rev Med Chir Soc Med Nat Iasi; 1976; 80(3):437-40. PubMed ID: 1024240
    [No Abstract]   [Full Text] [Related]  

  • 30. In vitro methods for the evaluation of drug availability from suppositories: comparison between biological and artificial membranes.
    Realdon N; Ragazzi E; Morpurgo M; Ragazzi E
    Pharmazie; 2005 Oct; 60(10):756-60. PubMed ID: 16259123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Acetylsalicylic acid containing suppositories with lipophilik bases. 1. Manufacture by the molding process and investigation of physical parameters].
    Regdon E; Regdon G; Karolyi K
    Pharmazie; 1976; 31(2):114-6. PubMed ID: 959252
    [No Abstract]   [Full Text] [Related]  

  • 32. Suppository formulations as a potential treatment for nephropathic cystinosis.
    Buchan B; Kay G; Matthews KH; Cairns D
    J Pharm Sci; 2012 Oct; 101(10):3729-38. PubMed ID: 22778070
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A study of the effect of some emulsifying agents on drug release from suppository bases.
    WHITWORTH CW; LAROCCA JP
    J Am Pharm Assoc Am Pharm Assoc; 1959 Jun; 48(6):353-5. PubMed ID: 13654093
    [No Abstract]   [Full Text] [Related]  

  • 34. Influence of vehicle dielectric properties on acetaminophen bioavailability from polyethylene glycol suppositories.
    Pagay SN; Poust RI; Colaizzi JL
    J Pharm Sci; 1974 Jan; 63(1):44-7. PubMed ID: 4811284
    [No Abstract]   [Full Text] [Related]  

  • 35. Naproxen suppository: tissue response and comparative bioavailability.
    Sevelius H; Runkel R; Pardo A; Ortega E; Varady J; Segre E
    Eur J Clin Pharmacol; 1973 Jun; 6(1):22-5. PubMed ID: 4764370
    [No Abstract]   [Full Text] [Related]  

  • 36. Preparation and In vitro Evaluation of Naproxen Suppositories.
    Hargoli S; Farid J; Azarmi SH; Ghanbarzadeh S; Zakeri-Milani P
    Indian J Pharm Sci; 2013 Mar; 75(2):143-8. PubMed ID: 24019561
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The dynamics of the drug release from suppositories. Part 5: Liberation of chlorpromazine from suppository bases (author's transl)].
    Pasich J; Drobnicka B; Kasprzyk A
    Pharmazie; 1981; 36(1):20. PubMed ID: 7220580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlations between physical and drug release characteristics of polyethylene glycol suppositories.
    Kellaway IW; Marriott C
    J Pharm Sci; 1975 Jul; 64(7):1162-6. PubMed ID: 1151676
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Studies of consistency in lipophilic bases of suppositories and of drug-containing suppositories. 2. Determination of skittle flow point, of breaking strength of time of disintegration].
    Regdon G; Mezey G; Sztankovánszky K
    Pharmazie; 1973 Jul; 28(7):461-4. PubMed ID: 4767496
    [No Abstract]   [Full Text] [Related]  

  • 40. Hydrophilic suppository bases.
    WARD WC
    J Am Pharm Assoc Am Pharm Assoc; 1950 May; 39(5):265-6. PubMed ID: 15421915
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.